Experiment 67471
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | SCHUPPAN,D: HAHN,EG:. (2000). CLINICAL STUDIES WITH SILYMARIN: FIBROSIS PROGRESSION IS THE END POINT.. 2000(32) |
| Amount utilized | |
| Compound isolated | |
| Disease | A LETTER TO THE EDITOR STATING THAT CLINICAL TRIALS INVOLVING SILYMARIN SHOULD BE LONGER THAN 1 YR AND THE OUTCOME PARAMETERS SHOULD INCLUDED ASSESSMENT OF FIBROSIS PROGRESSION, AS WELL AS OTHER APARAMETERS OF LIVER FUNCTION. |
| Dose amount | 420.0 MG |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | HYDRO-ALCOHOLIC EXT |
| Gender | GIVEN TO BOTH SEXES |